| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Cost-effectiveness estimates | Living Goods | ||||||||||||||||||||||||
2 | ||||||||||||||||||||||||||
3 | ||||||||||||||||||||||||||
4 | Summary cost per DALY calculation | |||||||||||||||||||||||||
5 | Item | Burkina Faso | Keyna | Uganda | ||||||||||||||||||||||
6 | Number of baseline coverage | 21,854 | 3,743 | 516,111 | ||||||||||||||||||||||
7 | Number of endline coverage | 80,895 | 437,768 | 1,021,698 | ||||||||||||||||||||||
8 | Number of additional under five children treated | 59,041 | 434,025 | 505,587 | ||||||||||||||||||||||
9 | Estimated number of diarrhoea cases treated | 23,374 | 171,825 | 200,155 | ||||||||||||||||||||||
10 | Estimated number of pneumonia cases treated | 1,973 | 14,505 | 16,896 | ||||||||||||||||||||||
11 | Estimated number of malaria cases treated | 33,694 | 247,696 | 288,536 | ||||||||||||||||||||||
12 | Number of pregnancy registration completed | 16,406 | 49,735 | 36,011 | ||||||||||||||||||||||
13 | Number of maternal death averted | 12 | 22 | 18 | ||||||||||||||||||||||
14 | Number of under five death averted | 33 | 450 | 350 | ||||||||||||||||||||||
15 | Remaining life expectancy at the age of pregnancy related death | 25 | 24 | 24 | ||||||||||||||||||||||
16 | Number of DALYs averted from maternal mortality | 293 | 534 | 444 | ||||||||||||||||||||||
17 | Life expectancy of under five | 28 | 28 | 29 | ||||||||||||||||||||||
18 | Number of DALYs averted from mortality among under five | 947 | 12,830 | 9,972 | ||||||||||||||||||||||
19 | Total DALYs averted | 1,240 | 13,363 | 10,417 | ||||||||||||||||||||||
20 | Total costs of the interventions | 114,345 | 105,590 | 1,089,767 | ||||||||||||||||||||||
21 | Cost per DALY averted US$ | 92 | 8 | 105 | ||||||||||||||||||||||
22 | Cost per DALY averted without discounting US$ | 44 | 4 | 45 | ||||||||||||||||||||||
23 | Note: Data in rows 13–22 are sourced from or rely on data from the 2024 version of the Living Goods Impact Tool. The tool has since been redesigned with updated methodology in collaboration with our health economist and is currently undergoing internal validation. These figures were not subject to the updated validation process prior to being shared with The Life You Can Save. | |||||||||||||||||||||||||
24 | ||||||||||||||||||||||||||
25 | ||||||||||||||||||||||||||
26 | Monitoring data | |||||||||||||||||||||||||
27 | Countries | |||||||||||||||||||||||||
28 | 2024 | 2024 | 2024 | |||||||||||||||||||||||
29 | Burkina Faso | Kenya | Uganda | Comments | ||||||||||||||||||||||
30 | Name of the programme | Living Goods (no specific program name) | ||||||||||||||||||||||||
31 | Brief description of the programme | Living Goods equips community health workers (CHWs) to deliver RMNCH care and partners with African governments to strengthen their community health programs. | ||||||||||||||||||||||||
32 | Objective of the programme | To deliver high-quality, data-driven community healthcare and build stronger, government-led community health systems. | ||||||||||||||||||||||||
33 | Outcome description | Reduced morbidity/mortality and increased government ownership/investment in community health for greater sustainability. | ||||||||||||||||||||||||
34 | Target group (age specific/description) | Living Goods primarily targets under-5 children and women of reproductive age (15-49). | ||||||||||||||||||||||||
35 | Total Target Population by age group/target group in number | 85,238 sick children in Burkina Faso in 2024. Please note Living Goods does not break out the target number of women of reproductive age, but instead target the number of pregnancy registrations (13,565 in 2024). CHWs are not currently providing family planning services in our Burkina Faso program. | 793,922 sick children in Kenya in 2024. Please note Living Goods does not break out the target number of women of reproductive age, but instead target the number of pregnancy registrations (58,295) and couple years protection (268,656). | 727,056 sick children in Uganda in 2024. Please note Living Goods does not break out the target number of women of reproductive age, but instead target the number of pregnancy registrations (38,610) and couple years protection (89,100). | ||||||||||||||||||||||
36 | Number of population reached for each group | Living Goods reached 487,800 people in Burkina Faso in 2024. | Living Goods 2,695,040 people in Kenya in 2024. | We reached 1,418,400 people in Uganda in 2024. | Kenya: 2024 service volumes may be modestly under-reported due to the nationwide transition to the Ministry of Health’s eCHIS platform and some associated reporting downtime. | |||||||||||||||||||||
37 | Gender distribution of the beneficiaries | Across their programs, Living Goods estimates about 84% female and 16% male beneficiaries. | ||||||||||||||||||||||||
38 | Programme start date | 2023 | 2015 | 2008 | ||||||||||||||||||||||
39 | Duration of the programme (years) | 2 | 10 | 17 | ||||||||||||||||||||||
40 | List of outcome indicators (prevention of morbidity / mortality) | |||||||||||||||||||||||||
41 | Indicator 1 | Under-5 sick child treatments or referrals for malaria, pneumonia, and diarrhea | ||||||||||||||||||||||||
42 | Indicator 2 | Pregnancy registrations | ||||||||||||||||||||||||
43 | Indicator 3 | Couple years protection | ||||||||||||||||||||||||
44 | Baseline status of the outcome indicators | |||||||||||||||||||||||||
45 | Indicator 1 | 2023: 14.7 U5 sick child treatments per month per CHW; 21,854 total | 2015: 3,743 U5 sick child treatments total | 2015: 516,111 U5 sick child treatments total | Please note for baseline indicators Living Goods used the earliest year where they have data easily available from their programs: this was 2023 for Burkina Faso and 2015 for Kenya and Uganda. | |||||||||||||||||||||
46 | Indicator 2 | 2023: 2.6 pregnancy registrations per month per CHW; 6,906 total | 2015: 2,253 pregnancy registrations total | 2015: 151,448 pregnancy registrations total | ||||||||||||||||||||||
47 | Indicator 3 | N/A | 2019: 2,828 couple years protection total | 2019: 22,157 couple years protection total | Burkina Faso: Not all indicators were available throughout 2024 while new digital tools and reporting systems were being rolled out. | |||||||||||||||||||||
48 | Endline status of the outcome indicators after evaluation or effect size of the programme after evaluation | |||||||||||||||||||||||||
49 | Indicator 1 | 2024: 19 U5 sick child treatments per month per CHW; 80,895 total | 2024: 7.9 U5 sick child treatments per month per CHW; 437,768 total | 2024: 33 U5 sick child treatments per month per CHW; 1,021,698 total | ||||||||||||||||||||||
50 | Indicator 2 | 2024: 3.5 pregnancy registrations per month per CHW; 23,312 total | 2024: 1 pregnancy registration per month per CHW; 51,988 total | 2024: 1.2 pregnancy registrations per month per CHW; 36,011 total | ||||||||||||||||||||||
51 | Indicator 3 | N/A | 2024: 2.3 couple years protection per month per CHW; 134,922 total | 2024: 4.6 couple years protection per month per CHW; 132,499 total | ||||||||||||||||||||||
52 | Cost of the programme/intervention in details | |||||||||||||||||||||||||
53 | Total Program Costs per Average Number of CHWs per learning site | $3,452 | $1,904 | $2,140 | Costs under this row relate to the Total Program Costs per Average Number of CHWs per learning site. (Total Program Cost = DESC components + Program Management and Program Administration costs). The costs in Row 29 and 30 are specific to the cost of digital equipment and cost of commodities/supplies for the learning sites respectively. | |||||||||||||||||||||
54 | Cost of capital items | $79,860 | $30,069 | $79,493 | Cost of capital items with lifetime more than one year e.g., electronic device | |||||||||||||||||||||
55 | Costs of recurrent items | $34,485 | $75,521 | $1,010,274 | Costs of consumable items e.g., supplies | |||||||||||||||||||||
56 | Total costs | $114,345 | $105,590 | $1,089,767 | ||||||||||||||||||||||
57 | Other statistics | |||||||||||||||||||||||||
58 | Age Standardized life expectancy (years ) | 62.3 | 61.4 | 63.6 | ||||||||||||||||||||||
59 | Source for row above | https://data.who.int/countries/854 | https://humancapital.worldbank.org/en/economy/KEN | https://data.who.int/countries/800 | ||||||||||||||||||||||
60 | Disability weight for the specific morbidity | 0.191 | 0.21 | 0.188 | GBD/WHO life tables for each country - https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_daly-methods.pdf | |||||||||||||||||||||
61 | Maternal mortality per 100000 | 242 | 149 | 170 | Maternal mortality. https://data.worldbank.org/indicator/SH.STA.MMRT | |||||||||||||||||||||
62 | Maternal mortality per person | 0.00242 | 0.00149 | 0.0017 | ||||||||||||||||||||||
63 | Reduction of maternal mortality for CHWs intervention (assumptions based on the review) | 0.3 | 0.3 | 0.3 | We assume this will be 30% considering the vulnerable community. Source https://pubmed.ncbi.nlm.nih.gov/25803792/ | |||||||||||||||||||||
64 | Reduction of death per mother | 0.000726 | 0.000447 | 0.00051 | ||||||||||||||||||||||
65 | Maternal deaths | Mean age 24.2 years (±6.5) among maternal deaths (range 14–43) | National Confidential Enquiry into Maternal Deaths dataset (analysis of 484 deaths) reported a mean age 28.8 year | City-wide analysis in Kampala (2016–2021) reported an average age 28 years (±6) among 358 maternal deaths. | ||||||||||||||||||||||
66 | Source for maternal deaths | https://pmc.ncbi.nlm.nih.gov/articles/PMC6328931/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC9544179/? | https://doi.org/10.29392/001c.116248 | ||||||||||||||||||||||
67 | Diarrhoea | 11% | 7% | 8% | ||||||||||||||||||||||
68 | Source for Diarrhoea rates | https://doi.org/10.1016/j.ijans.2019.100175 | http://dx.doi.org/10.1016/j.ijid.2009.07.021 | https://doi.org/10.1186/s12887-022-03448-2 | ||||||||||||||||||||||
69 | Pneumonia | 8% | 7% | 0% | ||||||||||||||||||||||
70 | Source for Pneumonia rates | https://www.sciencedirect.com/science/article/pii/S1201971220301831#tbl0005 | https://pmc.ncbi.nlm.nih.gov/articles/PMC4241029/#b18 | https://pubmed.ncbi.nlm.nih.gov/39761235/ | ||||||||||||||||||||||
71 | Malaria | 1% | 21% | NA | ||||||||||||||||||||||
72 | Source for Malaria rates | https://pmc.ncbi.nlm.nih.gov/articles/PMC7143776/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC7143776/ | |||||||||||||||||||||||
73 | Extracted data to calculate DALY | |||||||||||||||||||||||||
74 | Baseline indicators | |||||||||||||||||||||||||
75 | Total treatment of under five children | 21,854 | 3,743 | 516,111 | ||||||||||||||||||||||
76 | Total pregnancy registration | 6,906 | 2,253 | 151,448 | ||||||||||||||||||||||
77 | Couple year protection | 0 | 2,828 | 22,157 | ||||||||||||||||||||||
78 | Endline indicator | https://gh.bmj.com/content/9/10/e016600 | ||||||||||||||||||||||||
79 | Total treatment of under five children | 80,895 | 437,768 | 1,021,698 | ||||||||||||||||||||||
80 | Total pregnancy registration | 23,312 | 51,988 | 36,011 | ||||||||||||||||||||||
81 | Couple year protection | 134,922 | 132,499 | |||||||||||||||||||||||
82 | Pneumonia | 2,703 | 14,630 | 34,144 | ||||||||||||||||||||||
83 | Diarrhoea | 32,025 | 173,307 | 404,477 | ||||||||||||||||||||||
84 | Malaria | 46,166 | 249,832 | 583,077 | 0.5 | 0.005 | 0.015 | |||||||||||||||||||
85 | Estimates | |||||||||||||||||||||||||
86 | Additional under five children | 59,041 | 434,025 | 505,587 | ||||||||||||||||||||||
87 | Additional mother enrolled for delivery care | 16,406 | 49,735 | 36,011 | ||||||||||||||||||||||
88 | Reduced maternal mortality | 11.91 | 22.23 | 18.37 | ||||||||||||||||||||||
89 | Average age at deaths among mother | 24.20 | 28.8 | 28 | ||||||||||||||||||||||
90 | Life expectancy at the age of death among mother | 45.5 | 42.95 | 43.85 | ||||||||||||||||||||||
91 | Discounted LE | 24.6 | 24 | 24.2 | ||||||||||||||||||||||
92 | Years Life Lost (YLL) | 293 | 534 | 444 | ||||||||||||||||||||||
93 | Deaths averted from Diarrhoea | 947 | 12,830 | 9,972 | Diarrhoea | Pneumonia | Malaria | |||||||||||||||||||
94 | Total YLL | 1,240 | 13,363 | 10,417 | BF | 11% | https://doi.org/10.1016/j.ijans.2019.100175 | 8% | https://www.sciencedirect.com/science/article/pii/S1201971220301831#tbl0005 | 1% | https://pmc.ncbi.nlm.nih.gov/articles/PMC7143776/ | |||||||||||||||
95 | Total costs of the interventions in US$ | 114,345 | 105,590 | 1,089,767 | KN | 7% | http://dx.doi.org/10.1016/j.ijid.2009.07.021 | 7% | https://pmc.ncbi.nlm.nih.gov/articles/PMC4241029/#b18 | 21% | https://pmc.ncbi.nlm.nih.gov/articles/PMC7143776/ | |||||||||||||||
96 | Cost per DALY averted US$ | 92.2 | 7.9 | 104.6 | UG | 8% | https://doi.org/10.1186/s12887-022-03448-2 | 0% | https://pubmed.ncbi.nlm.nih.gov/39761235/ | |||||||||||||||||
97 | ||||||||||||||||||||||||||
98 | Assumptions | |||||||||||||||||||||||||
99 | Number of mother registered by CHW: the difference (baseline-endline) for Uganda for pregnancy registration was ignored and considered as additional number of pregnancy registered due to the difference between baseline and endline is negative. Namely, the reported baseline was higher than what is reported in 2024. We assumed that the endline value captured the additional number of pregnant women that were registered. | |||||||||||||||||||||||||
100 | Assumed that ANC coverage increased by 10.2% due to the registration by CHW. | |||||||||||||||||||||||||